Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Washed Microbiota Transplantation for Tourette's Syndrome
NCT03764748Phase 1Recruiting
- Sponsor
- The Second Affiliated Hospital of Nanjing Medical University
- Start
- Apr 2024
- Primary completion
- Oct 2027
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of washed microbiota transplantation in Tourette syndrome (TS), sponsored by The Second Affiliated Hospital of Nanjing Medical University. Primary endpoint: Yale Global Tic Severity Scale-Total Tic Score at 6 months. Started Apr 2024; status: recruiting.
02
Drugs
washed microbiota transplantation
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on NCT03764748.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03764748.